Teva reaches its highest level since 2017 as investors embrace its transformation...
Teva Pharmaceutical Industries shares have risen about 20% in August, reaching their highest level since 2017. The Israeli drugmaker's market value now stands at $43.
5 billion amid its shift toward innovative medicines and an expanding pipeline.